Component

Respiration supported by SLC25A51 in human cells

Context-specific entity; species, compartment and exposure are stated on each claim.

1 recorded relationships. Experimental role, claim status and evidence remain attached to each record.

How nutrients influence it

Every nutrient with a recorded effect on this component, credited to the nutrient that acted rather than the chapter that recorded it. Open a nutrient to see the findings and the conditions they were measured under.

How nutrients reach it in more than one step

Chains of two or more recorded steps that end here, grouped by the nutrient they start from. Each step is a separate finding, so a chain is a route a mechanism could take, not proof that it does.

Tracing routes…

What it does

Every recorded relationship this component is part of, grouped by its role. Plain wording comes first; the technical statement follows.

Recorded relationships

What acts on it

  1. MCART1/SLC25A51-null human cells had reduced mitochondrial NAD+/NADH, TCA-cycle flux, respiration and complex-I activity.

    Experimental context and source evidence
    availability_state
    machinery_impairment Imported condition classification; unverified.
    evidence_access
    Primary full text
    experimental_model
    Human cultured-cell knockout, metabolomics and isolated-mitochondrial assays.
    limitations
    Cellular transporter disruption, not proof that oral NAD crosses all membranes or treats a transporter disorder.
    nutrient_topic
    NAD+ collection; molecular form, preparation, species, exposure and manipulation remain explicit. · NAD+
    plain_language
    A functioning NAD supply outside mitochondria cannot compensate for a broken mitochondrial entry route.
    primary_references
    MCART1/SLC25A51 is required for mitochondrial NAD transport. · 2020 · https://pubmed.ncbi.nlm.nih.gov/33087354/ · DOI 10.1126/sciadv.abe5310
    trigger_kind
    machinery_impairment Imported condition classification; unverified.

    NAD+: compartmental supply, consumption and cross-nutrient mechanisms (2026-09-19) · lines 36–42

    AI-assisted research curation; primary references, access levels and experimental limitations individually identified. Not publisher full text. · supports · Human cultured-cell knockout, metabolomics and isolated-mitochondrial assays. · source_derived_draft · unverified_draft

    ## nad-plus-slc51-respiration A functioning NAD supply outside mitochondria cannot compensate for a broken mitochondrial entry route. MCART1/SLC25A51-null human cells had reduced mitochondrial NAD+/NADH, TCA-cycle flux, respiration and complex-I activity. Model: Human cultured-cell knockout, metabolomics and isolated-mitochondrial assays. Limitations: Cellular transporter disruption, not proof that oral NAD crosses all membranes or treats a transporter disorder. Evidence access: Primary full text MCART1/SLC25A51 is required for mitochondrial NAD transport. · 2020 · https://pubmed.ncbi.nlm.nih.gov/33087354/ · DOI 10.1126/sciadv.abe5310
    Complete structured claim and evidence

In the sources

Preserved passages that mention this component, quoted exactly. Open one to read it in context.

    This is a research prototype built from draft material. It is not medical advice, and its statements still await verification against the original studies.

    Evidence, AI assistance and curation standards